Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Epigenetics in Drug Discovery

Christian Fritz's Biography

Christian Fritz, Vice President, Syros

Christian Fritz, Ph.D., Vice President, Biology Christian joins Syros from Infinity Pharmaceuticals and brings with him more than 15 years of drug discovery experience. At Infinity, he was in charge of biochemistry, cell biology and pharmacology working on compound mechanism of action, novel indications/combinations and the early drug pipeline. He also was instrumental in establishing a molecular pathology group that has developed multiple clinical biomarkers to help predict patient response to Infinity drug candidates. Before Infinity, Christian was at Millennium Pharmaceuticals where he was involved in target discovery and validation, HTS, hit-to-lead and lead optimization. Christian obtained his degree in biochemistry from the University of Hannover and his Ph.D. in molecular biology/genetics from the University of Cologne, working at the Max-Planck Institute. He did postdoctoral work at Harvard and UMass Medical School.

Christian Fritz Image

Application of Super-enhancer Analysis for Drug Discovery

Tuesday, 26 January 2016 at 11:30

Add to Calendar ▼2016-01-26 11:30:002016-01-26 12:30:00Europe/LondonApplication of Super-enhancer Analysis for Drug DiscoveryEpigenetics in Drug Discovery in Cambridge, UKCambridge,

‘Super-enhancers’ regulate genes important for cell identity and cell fate. We are mapping super-enhancers in patient tumors in order to identify novel oncology targets as well as accelerate existing small molecules into the clinic.

Add to Calendar ▼2016-01-26 00:00:002016-01-27 00:00:00Europe/LondonEpigenetics in Drug DiscoveryEpigenetics in Drug Discovery in Cambridge, UKCambridge,